Community-associated methicillin-resistant Staphylococcus aureus: The way to the wound is through the nose

Journal of Infectious Diseases

Volumn 193, Issue 2, 2006, Pages 169-171

  Creech II, Clarence Buddy ^a,b   Talbot, Thomas R ^a   Schaffner, William ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; LEUKOCIDIN; PANTON VALENTINE LEUKOCIDIN; PNEUMOCOCCUS VACCINE; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BONE INFECTION; COMMUNITY; EDITORIAL; GENE CASSETTE; HOST PATHOGEN INTERACTION; HUMAN; INCIDENCE; INFECTION RISK; INFECTIOUS ARTHRITIS; MEC IV GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NOSE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; WOUND INFECTION;

CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 30944463417     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500432     Document Type: Editorial

References (20)

1. Elek SD. The staphylococci: ecologic perspectives. Opening remarks. Ann NY Acad Sci 1965; 128:1-3.
2. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylacoccus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172-9 (in this issue).
3. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
4. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978-84.
5. Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005; 24:617-21.
6. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39:971-9.
7. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34:425-33.
8. Cheng Immergluck L, Kanungo S, Schwartz A, McIntyre A, Schreckenberger PC, Diaz PS. Prevalence of Streptococcus pneumoniae and Staphylococcus aureus nasopharyngeal colonization in healthy children in the United States. Epidemiol Infect 2004; 132:159-66.
9. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 2001; 20:763-7.
10. Nakamura MM, Rohling KL, Shashaty M, Lu H, Tang YW, Edwards KM. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 2002; 21:917-22.
11. Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J 1999; 18:410-4.
12. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36:131-9.
13. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-91.
14. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115:642-8.
15. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40:941-7.
16. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL. Community-acquired, methicillin-resistant and methicillin- susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701-6.
17. Pan ES, Diep BA, Charlebois ED, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus-and their relation to community-associated disease activity. J Infect Dis 2005; 192:811-8.
18. Alfaro CC, Mascher-Denen M, Fergie JE, Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's Hospital [abstract 1071]. In: Program and abstracts of the 43rd annual meeting of the Infectious Diseases Society of America (San Francisco). Infectious Diseases Society of America, 2005.
19. Jones T, Erwin P, Creech CB, Baird SG, Woron A, Schaffner W. Familial outbreaks of invasive community-associated MRSA [abstract 1054]. In: Program and abstracts of the 43rd annual meeting of the Infectious Diseases Society of America (San Francisco). Infectious Diseases Society of America, 2005.
20. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-6.